Kidney COP Patented Supplement for Calcium Oxalate Stones

Description

Supporting studies and invitro testing results documenting the 99% inhibition in the rate of calcium oxalate stone crystal growth can be found in the United States Patent 9,233,135, under Table 2 Labeled Data Analysis for Slope Test. Control Vehicle & Test Solution 1. Many of Kidney C.O.P.’s active ingredients (or combination of) have been tested in clinical studies & have shown to have an effect inhibiting calcium oxalate crystal growth. Many of these clinical studies are found in the five patents: 9,233,135; 9,492,491; 9,623,006; 9,789,152; 10,471,115 – pgs 1 – 3 of each patent. Just a few of these clinical studies are listed below: -J Altern Complement Med 2008 Dec;14(10):1287-90. doi: 10.1089/acm.2008.0189. -Patankar S1, Dobhada S, Bhansali M, Khaladkar S, Modi J. Br J Urol. 1991 Mar;67(3):237-40. -Ebisuno S1, Morimoto S, Yasukawa S, Ohkawa T. J Urol. 1997 Dec;158(6):2069-73. -Ettinger B1, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A., J Urol. 2009 Mar;181(3):1145-50. doi: 10.1016/j.juro.2008.11.014. 2009 Jan 18. -Soygür T1, Akbay A, Küpeli S. ,J Endourol. 2002 Apr;16(3):149-52. -R. Gopakumara Pillai Consultant Urologist, District Hospital, Kollam, Kerala, India., Ancient science of life 07/1995; 15(1):2-6., PubMed -Int Urol Nephrol. 1988;20(4):353-9. Mitwalli A1, Ayiomamitis A, Grass L, Oreopoulos DG. -S N Gershoff, E L Prien. PMID: 6023850 DOI: 10.1093/ajcn/20.5.393